Assistant Professor, Medicine - Cardiovascular Medicine, Stanford University Medical Center
Cardiology
Dr. Euan Ashley, MD
|
|
Give Review
Euan Ashley, MD practices Cardiology. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Euan Ashley is also published. He has 100 publications published. The lastest publication: "Evidence of autonomic dysreflexia during functional electrical stimulation in individuals with spinal cord injuries.' He accepts all Medicare patients.
Publications
- Direct-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statement.
- The Undiagnosed Diseases Network of the National Institutes of Health: A National Extension.
- Gender Differences in Ventricular Remodeling and Function in College Athletes, Insights from Lean Body Mass Scaling and Deformation Imaging.
- Comparison of left ventricular manual versus automated derived longitudinal strain: implications for clinical practice and research.
- Redox regulation of vascular remodeling.
- Promise of Precision Medicine--Reply.
- Hypertrophic Cardiomyopathy: can the horse be put back in the barn?
- RNA-Seq identifies novel myocardial gene expression signatures of Heart failure.
- Additive prognostic value of a cardiopulmonary exercise test score in patients with Heart failure and intermediate risk.
- A long noncoding RNA protects the Heart from pathological hypertrophy.
- Stable, covalent attachment of laminin to microposts improves the contractility of mouse neonatal cardiomyocytes.
- Long-term outcomes of septal reduction for obstructive hypertrophic Cardiomyopathy.
- Interpreting whole-genome sequencing--reply.
- Molecular Diagnosis of Long-QT Syndrome at 10 Days of Life by Rapid Whole Genome Sequencing.
- Guidelines for investigating causality of sequence variants in human Disease.
- Latent obstruction and left Atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy.
- WHOLE EXOME SEQUENCING REVEALS TOPBP1 AS A NOVEL GENE IN IDIOPATHIC Pulmonary ARTERIAL HYPERTENSION.
- Clinical interpretation and implications of whole-genome sequencing.
- Exercise capacity and paroxysmal Atrial fibrillation in patients with hypertrophic cardiomyopathy.
- A neural network approach to predicting outcomes in Heart failure using cardiopulmonary exercise testing.
- Unexplained Double-Chambered Left Ventricle Associated with Contracting Right Ventricular Aneurysm and Right Atrial Enlargement.
- Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic Heart failure.
- Prevalence and Clinical Correlates of Right Ventricular Dysfunction in Patients With Hypertrophic Cardiomyopathy.
- Race Differences in Ventricular Remodeling and Function Among College Football Players.
- Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic Cardiomyopathy.
- Impact of cardiorespiratory fitness on the obesity paradox in patients with Heart failure.
- Validation of a cardiopulmonary exercise test score in Heart failure.
- The prognostic significance of Heart rate recovery is not dependent upon maximal effort in patients with Heart failure.
- Cardiopulmonary and noninvasive hemodynamic responses to exercise predict outcomes in Heart failure.
- Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical Disease.
- Abnormal electrocardiographic findings in athletes: recognising changes suggestive of Cardiomyopathy.
- Normal electrocardiographic findings: recognising physiological adaptations in athletes.
- Electrocardiographic interpretation in athletes: the 'Seattle criteria'.
- Physical activity and other health behaviors in adults with hypertrophic Cardiomyopathy.
- Abnormal calcium handling properties underlie familial hypertrophic Cardiomyopathy pathology in patient-specific induced pluripotent stem cells.
- A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with Heart failure.
- APJ acts as a dual receptor in cardiac hypertrophy.
- The Prognostic Utility of Cardiopulmonary Exercise Testing Stands the Test of Time in Patients With Heart Failure.
- Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic Cardiomyopathy.
- Apelin enhances directed cardiac differentiation of mouse and human embryonic stem cells.
- Patient-specific induced pluripotent stem cells as a model for familial dilated Cardiomyopathy.
- Personal omics profiling reveals dynamic molecular and medical phenotypes.
- Performance comparison of whole-genome sequencing platforms.
- Phased whole-genome genetic risk in a family quartet using a major allele reference sequence.
- Systems biology of Heart failure, challenges and hopes.
- Genetic analysis in cardiovascular Disease: a clinical perspective.
- The concept of ventricular reserve in Heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction.
- Gene coexpression network topology of cardiac development, hypertrophy, and Failure.
- Extremely elevated lipoprotein(a), combined Hyperlipidemia, and premature atherosclerosis in a Chinese family.
- Effect of gender on computerized electrocardiogram measurements in college athletes.
- Measurement precision in the optimization of cardiac resynchronization therapy.
- Defining the limits of athlete's Heart: implications for screening in diverse populations.
- Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes.
- Addition of the electrocardiogram to the preparticipation examination of college athletes.
- A new era in clinical genetic testing for hypertrophic Cardiomyopathy.
- Endogenous regulation of cardiovascular function by apelin-APJ.
- The medical device safety act of 2009: clarifying preemption.
- Re: A prospective randomized evaluation of VV delay optimization in CRT-D recipients: echocardiographic observations from the RHYTHM II ICD study.
- Electrocardiographic predictors of Atrial fibrillation.
- Mechanisms of exercise intolerance in patients with hypertrophic Cardiomyopathy.
- Apelin prevents aortic Aneurysm formation by inhibiting macrophage inflammation.
- Statin use and ventricular Arrhythmias during clinical treadmill testing.
- A general framework for dose optimization.
- Age and double product (systolic blood pressure x Heart rate) reserve-adjusted modification of the Duke Treadmill Score nomogram in men.
- Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.
- Low-dose growth hormone is cardioprotective in uremia.
- Genetics of arrhythmia: Disease pathways beyond ion channels.
- Does size matter? Clinical applications of scaling cardiac size and function for body size.
- Pharmacogenetics of Heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.
- Ventricular Arrhythmias during clinical treadmill testing and prognosis.
- Frontiers in nephrology: genomic approaches to understanding the molecular basis of atherosclerosis.
- Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.
- Prognostic value of Heart rate increase at onset of exercise testing.
- Emerging therapies for the management of decompensated Heart failure: from bench to bedside.
- Network analysis of human in-stent restenosis.
- Angiotensin-converting enzyme genotype predicts cardiac and autonomic responses to prolonged exercise.
- Pathway analysis of Coronary atherosclerosis.
- Signature patterns of gene expression in mouse atherosclerosis and their correlation to human Coronary disease.
- Preoperative cardiac evaluation: mechanisms, assessment, and reduction of risk.
- Mouse strain-specific differences in vascular wall gene expression and their relationship to vascular Disease.
- Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation.
- Electrocardiographic arrhythmia risk testing.
- Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.
- Cardiac neuronal nitric oxide synthase isoform regulates Myocardial contraction and calcium handling.
- Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.
- Establishing Disease causality for a novel gene variant in familial dilated cardiomyopathy using a functional in-vitro assay of regulated thin filaments and human card...
- Personalized preventive medicine: genetics and the response to regular exercise in preventive interventions.
- A Balanced Look at the Implications of Genomic (and Other "Omics") Testing for Disease Diagnosis and Clinical Care.
- How does morphology impact on diastolic function in hypertrophic Cardiomyopathy? A single centre experience.
- Rat model of veno-arterial extracorporeal membrane oxygenation.
- A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
- Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in...
- Human immunodeficiency virus and respiratory infection.
- Hearts from DCD donors display acceptable biventricular function after Heart transplantation in pigs.
- Evidence of autonomic dysreflexia during functional electrical stimulation in individuals with spinal cord injuries.
- The detection and treatment of Plasmodium falciparum malaria: time for change.
- Is stress Cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death?
- Medical education - beyond tomorrow? The new doctor - Asclepiad or Logiatros?
- Exercise oscillatory ventilation reflects diminished quality of life and perceived functional capacity in patients with Heart failure.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Stanford University -
University of Glasgow Faculty of Medicine
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1497792204 | |
| NPPES Provider LastName | ASHLEY | |
| NPPES Provider FirstName | EUAN | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 729.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497792204 |
| Last Name Of The Provider | ASHLEY |
| First Name Of The Provider | EUAN |
| View All |
Similar Doctors
|
|
Dr. Matthew T. Wheeler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellamae Stadnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dipanjan Banerjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley G. Rockson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen J. Friday, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francois Haddad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley C. Nelson, MD |